Cincinnati Children’s

STAQ Pharma, Inc. is a Denver-based company that specializes in the manufacturing and sale of compounded pharmaceutical medications. Founded in 2018, it operates a cGMP outsourcing facility that produces a range of compounded medications, including prefilled syringes for hospital procedures. The company emphasizes safety, quality, and transparency in its offerings, providing both non-sterile and sterile solutions, as well as sterile-to-sterile repackaging services. STAQ Pharma utilizes advanced inventory systems to forecast demand and ensure timely availability of critical products for healthcare facilities. Through its own pharmaceutical facilities and online store, STAQ Pharma aims to enhance access to high-quality compounded medications.

Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.

Airway Therapeutics, Inc. develops protein therapeutics for applications in the lung and pediatrics disciplines. Its products include recombinant human surfactant protein-D for the prevention of bronchopulmonary dysplasia in premature infants; and AT100, a protein replacement therapy targeting bronchopulmonary dysplasia. Airway Therapeutics, Inc. was incorporated in 2008 and is based in Cincinnati, Ohio with additional offices in Marietta, Georgia.

Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.

Airway Therapeutics, Inc. develops protein therapeutics for applications in the lung and pediatrics disciplines. Its products include recombinant human surfactant protein-D for the prevention of bronchopulmonary dysplasia in premature infants; and AT100, a protein replacement therapy targeting bronchopulmonary dysplasia. Airway Therapeutics, Inc. was incorporated in 2008 and is based in Cincinnati, Ohio with additional offices in Marietta, Georgia.

Airway Therapeutics, Inc. develops protein therapeutics for applications in the lung and pediatrics disciplines. Its products include recombinant human surfactant protein-D for the prevention of bronchopulmonary dysplasia in premature infants; and AT100, a protein replacement therapy targeting bronchopulmonary dysplasia. Airway Therapeutics, Inc. was incorporated in 2008 and is based in Cincinnati, Ohio with additional offices in Marietta, Georgia.

Airway Therapeutics, Inc. develops protein therapeutics for applications in the lung and pediatrics disciplines. Its products include recombinant human surfactant protein-D for the prevention of bronchopulmonary dysplasia in premature infants; and AT100, a protein replacement therapy targeting bronchopulmonary dysplasia. Airway Therapeutics, Inc. was incorporated in 2008 and is based in Cincinnati, Ohio with additional offices in Marietta, Georgia.

Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.

Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.

Claritas Genomics, Inc. provides genetic diagnostic testing and research services. The company offers clinical exome analysis, pediatric neurology interest assay analysis, single gene sequencing, single gene deletion/duplication assay analysis, and pharmaceutical and biotechnology services. It serves hospitals and medical centers. The company was incorporated in 2012 and is based in Cambridge, Massachusetts. Claritas Genomics, Inc. operates as a subsidiary of The Children's Hospital Corporation.

Assurex Health is a personalized medicine company dedicated to helping clinicians determine the right medication for individual patients with medical conditions. Assurex Health’s proprietary Genesight® technology is based on pharmacogenomics – the study of the genetic factors that influence an individual’s response to drug treatments – as well as evidence-based medicine and clinical pharmacology.

Airway Therapeutics, Inc. develops protein therapeutics for applications in the lung and pediatrics disciplines. Its products include recombinant human surfactant protein-D for the prevention of bronchopulmonary dysplasia in premature infants; and AT100, a protein replacement therapy targeting bronchopulmonary dysplasia. Airway Therapeutics, Inc. was incorporated in 2008 and is based in Cincinnati, Ohio with additional offices in Marietta, Georgia.

Assurex Health is a personalized medicine company dedicated to helping clinicians determine the right medication for individual patients with medical conditions. Assurex Health’s proprietary Genesight® technology is based on pharmacogenomics – the study of the genetic factors that influence an individual’s response to drug treatments – as well as evidence-based medicine and clinical pharmacology.

QI Healthcare Inc. specializes in developing quality improvement software aimed at enhancing healthcare outcomes, particularly for children. Founded in 2012 and based in Cincinnati, Ohio, the company offers a range of software products, including the Surgical Outcomes Collection System. This application integrates data from hospital systems, including Electronic Medical Records (EMR), to facilitate comprehensive analyses of surgical cases. By identifying areas for improvement, QI Healthcare enables hospitals to enhance their care delivery and operational efficiency.